Recent Updates
Recently added Catalysts
ARWR Positive Sentiment

Arrowhead Pharmaceuticals to Participate in Upcoming Investor Conferences

Monday, November 9, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Arrowhead Pharmaceuticals announced its participation in several upcoming investor conferences. The company will present at the Jefferies Global Healthcare Conference and Citi's Global Healthcare Conference. These events provide opportunities for investor engagement and visibility in the healthcare sector.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in major investor conferences announced.
  • Engagement with investors through fireside chat presentations.
  • Opportunities for visibility and networking in the healthcare sector.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+6%
120-day peak, hindsight
Typical move
4.4%
average across 6 past catalysts
Cash runway
~24 mo
Low dilution risk
Lead asset
Plozasiran
Phase 3 · Severe Hypertriglyceridemia

Full Press Release Details

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming investor events:2026 Jefferies Global Healthcare Conference in London – November 16-19, 2026Type: Fireside Chat PresentationDate/Time: November 18, 2026, 11:00 am GMTCiti’s 2026 Global Healthcare Conference – November 30 - December 3, 2026Type: Fireside Chat PresentationDate/Time: December 2, 2026, 2:20 pm ESTPiper Sandler 38th Annual Hea

Frequently Asked Questions

What conferences will Arrowhead Pharmaceuticals attend?

Arrowhead will attend the Jefferies and Citi Global Healthcare Conferences.

When is the Jefferies Global Healthcare Conference?

The Jefferies conference is scheduled for November 16-19, 2026.

What type of presentation will Arrowhead give?

Arrowhead will present in a fireside chat format at both conferences.

When is Arrowhead's presentation at Citi's conference?

Arrowhead's presentation at Citi's conference is on December 2, 2026.

ShareAdd on Google
Tags: ARWR Arrowhead Pharmaceuticals investor conferences healthcare Jefferies
Last updated: Nov 9, 2026

Biotech snapshot

Cash runway
$1602M liquidity · $59M/mo burn
~24 mo
Low dilution risk
Lead asset
PlozasiranPhase 3
Severe Hypertriglyceridemia →

Catalyst track record

+6%
best trade around ARWR's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for ARWR.

See every catalyst's timing & PoA →